3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Pain
2
Waldenstrom Macroglobulinemia
1
Urinary Tract Infections
1
Thrombocythemia, Essential
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sezary Syndrome
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Pneumonia
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
Caspofungin
3
liposomal amphotericin B
2
Itraconazole
2
Fluconazole
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Voriconazole
1
Vecuronium Bromide
1
Vancomycin
1
Valacyclovir
1
Tranexamic Acid
1
Tobramycin
1
Therapeutics
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Ribavirin
1
Radiotherapy
1
Polymerase Chain Reaction
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Pentetic Acid
1
Palivizumab
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Moxifloxacin
1
Molindone
1
Minocycline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
Oxycodone
×
CNS
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled